CA1268780C - Groupes protecteurs n-hydroxyles et methode de preparation de 3-acylamino-1-hydroxy-2-azetidinones - Google Patents

Groupes protecteurs n-hydroxyles et methode de preparation de 3-acylamino-1-hydroxy-2-azetidinones

Info

Publication number
CA1268780C
CA1268780C CA 486940 CA486940A CA1268780C CA 1268780 C CA1268780 C CA 1268780C CA 486940 CA486940 CA 486940 CA 486940 A CA486940 A CA 486940A CA 1268780 C CA1268780 C CA 1268780C
Authority
CA
Canada
Prior art keywords
preparation
acylamino
azetidinones
hydroxy
protective groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA 486940
Other languages
English (en)
French (fr)
Other versions
CA1262357A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to CA000595566A priority Critical patent/CA1268780A/en
Publication of CA1262357A publication Critical patent/CA1262357A/en
Application granted granted Critical
Publication of CA1268780C publication Critical patent/CA1268780C/xx
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08—Hydroxylamino compounds or their ethers or esters
    • C07C239/20—Hydroxylamino compounds or their ethers or esters having oxygen atoms of hydroxylamino groups etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Accommodation For Nursing Or Treatment Tables (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cephalosporin Compounds (AREA)
CA 486940 1984-08-03 1985-07-17 Groupes protecteurs n-hydroxyles et methode de preparation de 3-acylamino-1-hydroxy-2-azetidinones Expired - Lifetime CA1268780C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000595566A CA1268780A (en) 1984-08-03 1989-04-03 N-hydroxyl protecting groups and process for the preparation of 3-acylamino-1-hydroxy-2-azetidinones

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/637,260 US4581170A (en) 1984-08-03 1984-08-03 N-hydroxyl protecting groups and process and intermediates for the preparation of 3-acylamino-1-hydroxy-2-azetidinones

Publications (2)

Publication Number Publication Date
CA1262357A CA1262357A (en) 1989-10-17
CA1268780C true CA1268780C (fr) 1990-05-08

Family

ID=24555200

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 486940 Expired - Lifetime CA1268780C (fr) 1984-08-03 1985-07-17 Groupes protecteurs n-hydroxyles et methode de preparation de 3-acylamino-1-hydroxy-2-azetidinones

Country Status (12)

Country Link
US (1) US4581170A (de)
EP (2) EP0170280B1 (de)
JP (2) JPH06732B2 (de)
AT (1) ATE58896T1 (de)
AU (2) AU589567B2 (de)
CA (1) CA1268780C (de)
DE (1) DE3580803D1 (de)
DK (1) DK353385A (de)
FI (1) FI852974A7 (de)
IE (2) IE58758B1 (de)
NZ (1) NZ212750A (de)
ZA (1) ZA855492B (de)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670553A (en) * 1982-01-04 1987-06-02 E. R. Squibb & Sons, Inc. 2-oxo-1-(aminocarbonylaminosulfonyl-aminocarbonyl)azetidines
DE3768523D1 (de) * 1986-02-18 1991-04-18 Squibb & Sons Inc ((2,2,2-trichloroethoxy)methoxy)amin.
US5037974A (en) * 1988-05-23 1991-08-06 Merck & Co., Inc. Cyclization process for synthesis of a beta-lactam carbapenem intermediate
US5631365A (en) 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
US6068993A (en) * 1997-07-02 2000-05-30 Biobras Sa Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
US6982251B2 (en) * 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
US7071181B2 (en) * 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
PT1363668E (pt) * 2001-01-26 2007-11-07 Schering Corp Combinaçoes de sequestrante(s) de ácidos biliares e inibidor(es) de absorção de esterol e tratamento de indicações vasculares
TW200840563A (en) * 2001-01-26 2008-10-16 Schering Corp Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(S) and treatments for vascular indications
US20060287254A1 (en) * 2001-01-26 2006-12-21 Schering Corporation Use of substituted azetidinone compounds for the treatment of sitosterolemia
IL156445A0 (en) * 2001-01-26 2004-01-04 Schering Corp Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
NZ542090A (en) * 2001-01-26 2006-09-29 Schering Corp Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
EP1385548B1 (de) * 2001-01-26 2007-05-23 Schering Corporation Kombinationen eines hemmers der sterolabsorption und eines kardiovaskulären wirkstoffes zur behandlung von kardiovaskulären indikationen
KR20070120617A (ko) * 2001-01-26 2007-12-24 쉐링 코포레이션 치환된 아제티딘온 화합물을 포함하는 약제학적 조성물
WO2002096415A2 (en) * 2001-05-25 2002-12-05 Schering Corporation Use of azetidinone substituted derivatives in the treatment of alzheimer's disease
US7056906B2 (en) * 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
DE60229406D1 (de) * 2001-09-21 2008-11-27 Schering Corp Verfahren zur behandlung oder verhinderung von vaskulärer entzündung mit sterol-absorbierungs- inhibitor(en)
EP1429756B1 (de) * 2001-09-21 2006-11-22 Schering Corporation Behandlung von xanthom mittels azetidinon-derivate als hemmer der sterol absorption
US20030119808A1 (en) * 2001-09-21 2003-06-26 Schering Corporation Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
CA2504916A1 (en) * 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
WO2004081004A1 (en) * 2003-03-07 2004-09-23 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
DE602004018617D1 (de) * 2003-03-07 2009-02-05 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
WO2004081002A1 (en) * 2003-03-07 2004-09-23 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
US7459442B2 (en) * 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
WO2005046797A2 (en) * 2003-11-05 2005-05-26 Schering Corporation Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions
US9420857B2 (en) 2013-03-04 2016-08-23 Hello Inc. Wearable device with interior frame
US9361572B2 (en) 2013-03-04 2016-06-07 Hello Inc. Wearable device with magnets positioned at opposing ends and overlapped from one side to another
US9420856B2 (en) 2013-03-04 2016-08-23 Hello Inc. Wearable device with adjacent magnets magnetized in different directions
US9737214B2 (en) 2013-03-04 2017-08-22 Hello Inc. Wireless monitoring of patient exercise and lifestyle
US9424508B2 (en) 2013-03-04 2016-08-23 Hello Inc. Wearable device with magnets having first and second polarities
US9526422B2 (en) 2013-03-04 2016-12-27 Hello Inc. System for monitoring individuals with a monitoring device, telemetry system, activity manager and a feedback system
US9149189B2 (en) 2013-03-04 2015-10-06 Hello, Inc. User or patient monitoring methods using one or more analysis tools
US9398854B2 (en) 2013-03-04 2016-07-26 Hello Inc. System with a monitoring device that monitors individual activities, behaviors or habit information and communicates with a database with corresponding individual base information for comparison
US9298882B2 (en) 2013-03-04 2016-03-29 Hello Inc. Methods using patient monitoring devices with unique patient IDs and a telemetry system
US9367793B2 (en) 2013-03-04 2016-06-14 Hello Inc. Wearable device with magnets distanced from exterior surfaces of the wearable device
US9532716B2 (en) 2013-03-04 2017-01-03 Hello Inc. Systems using lifestyle database analysis to provide feedback
US9204798B2 (en) 2013-03-04 2015-12-08 Hello, Inc. System for monitoring health, wellness and fitness with feedback
US9553486B2 (en) 2013-03-04 2017-01-24 Hello Inc. Monitoring system and device with sensors that is remotely powered
US9530089B2 (en) 2013-03-04 2016-12-27 Hello Inc. Wearable device with overlapping ends coupled by magnets of a selected width, length and depth
US8803366B2 (en) 2013-03-04 2014-08-12 Hello Inc. Telemetry system with wireless power receiver and monitoring devices
US9427160B2 (en) 2013-03-04 2016-08-30 Hello Inc. Wearable device with overlapping ends coupled by magnets positioned in the wearable device by an undercut
US9320434B2 (en) 2013-03-04 2016-04-26 Hello Inc. Patient monitoring systems and messages that send alerts to patients only when the patient is awake
US20140246502A1 (en) 2013-03-04 2014-09-04 Hello Inc. Wearable devices with magnets encased by a material that redistributes their magnetic fields
US9848776B2 (en) 2013-03-04 2017-12-26 Hello Inc. Methods using activity manager for monitoring user activity
US9339188B2 (en) 2013-03-04 2016-05-17 James Proud Methods from monitoring health, wellness and fitness with feedback
US9159223B2 (en) 2013-03-04 2015-10-13 Hello, Inc. User monitoring device configured to be in communication with an emergency response system or team
US9345404B2 (en) 2013-03-04 2016-05-24 Hello Inc. Mobile device that monitors an individuals activities, behaviors, habits or health parameters
US9427189B2 (en) 2013-03-04 2016-08-30 Hello Inc. Monitoring system and device with sensors that are responsive to skin pigmentation
US9462856B2 (en) 2013-03-04 2016-10-11 Hello Inc. Wearable device with magnets sealed in a wearable device structure
US9330561B2 (en) 2013-03-04 2016-05-03 Hello Inc. Remote communication systems and methods for communicating with a building gateway control to control building systems and elements
US9432091B2 (en) 2013-03-04 2016-08-30 Hello Inc. Telemetry system with wireless power receiver and monitoring devices
US9634921B2 (en) 2013-03-04 2017-04-25 Hello Inc. Wearable device coupled by magnets positioned in a frame in an interior of the wearable device with at least one electronic circuit
US9436903B2 (en) 2013-03-04 2016-09-06 Hello Inc. Wearable device with magnets with a defined distance between adjacent magnets
US9662015B2 (en) 2013-03-04 2017-05-30 Hello Inc. System or device with wearable devices having one or more sensors with assignment of a wearable device user identifier to a wearable device user
US9392939B2 (en) 2013-03-04 2016-07-19 Hello Inc. Methods using a monitoring device to monitor individual activities, behaviors or habit information and communicate with a database with corresponding individual base information for comparison
US9406220B2 (en) 2013-03-04 2016-08-02 Hello Inc. Telemetry system with tracking receiver devices
US9704209B2 (en) 2013-03-04 2017-07-11 Hello Inc. Monitoring system and device with sensors and user profiles based on biometric user information
US9430938B2 (en) 2013-03-04 2016-08-30 Hello Inc. Monitoring device with selectable wireless communication
US9357922B2 (en) 2013-03-04 2016-06-07 Hello Inc. User or patient monitoring systems with one or more analysis tools
US9345403B2 (en) 2013-03-04 2016-05-24 Hello Inc. Wireless monitoring system with activity manager for monitoring user activity
US9445651B2 (en) 2013-03-04 2016-09-20 Hello Inc. Wearable device with overlapping ends coupled by magnets
US9610030B2 (en) 2015-01-23 2017-04-04 Hello Inc. Room monitoring device and sleep analysis methods
US10009581B2 (en) 2015-01-02 2018-06-26 Fitbit, Inc. Room monitoring device
US9993197B2 (en) 2013-06-21 2018-06-12 Fitbit, Inc. Patient monitoring systems and messages that send alerts to patients only when the patient is awake

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2442240A1 (fr) * 1978-11-27 1980-06-20 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-substitue 7-amino thiazolyl acetamido cephalosporanique comportant un groupement eliminable sur le radical amino, leur procede de preparation et leur application a la synthese de produits actifs comme medicaments
US4337197A (en) * 1980-10-31 1982-06-29 E. R. Squibb & Sons, Inc. O-sulfated β-lactam hydroxamic acids and intermediates
US4939253A (en) * 1982-08-04 1990-07-03 E. R. Squibb & Sons, Inc. 2-oxoazetidin-1-yloxy acetic acids and analogs
NZ205642A (en) * 1982-10-06 1986-08-08 Squibb & Sons Inc Beta-lactams and pharmaceutical compositions

Also Published As

Publication number Publication date
ZA855492B (en) 1986-03-26
JPS6147445A (ja) 1986-03-07
AU614663B2 (en) 1991-09-05
JPH0662532B2 (ja) 1994-08-17
CA1262357A (en) 1989-10-17
US4581170A (en) 1986-04-08
AU4083589A (en) 1990-02-08
FI852974L (fi) 1986-02-04
JPH06732B2 (ja) 1994-01-05
ATE58896T1 (de) 1990-12-15
JPH069528A (ja) 1994-01-18
DK353385A (da) 1986-02-04
AU4535685A (en) 1986-02-06
EP0170280B1 (de) 1990-12-05
EP0371004A1 (de) 1990-05-30
IE58758B1 (en) 1993-11-03
FI852974A0 (fi) 1985-08-01
DK353385D0 (da) 1985-08-02
DE3580803D1 (de) 1991-01-17
NZ212750A (en) 1989-04-26
IE851917L (en) 1986-02-03
AU589567B2 (en) 1989-10-19
IE58771B1 (en) 1993-11-03
FI852974A7 (fi) 1986-02-04
EP0170280A1 (de) 1986-02-05

Similar Documents

Publication Publication Date Title
DK353385D0 (da) Fremstilling af 3-acylamino-1-hydroxy-2-azetidinoner og herved forekommende n-hydroxybeskyttelsesgrupper
ATE43788T1 (de) Benzoylharnstoffe mit antitumoraler wirkung.
MX159146A (es) Composicion mejorada plastificada de polivinilbutiral
IL61285A (en) 2-hydroxyalkyl-3,4,5-trihydroxy-piperidine compounds,their production and pharmaceutical compositions containing them
FI844232A0 (fi) Purinderivat.
IT1137543B (it) Produzione di oli per refrigerazione
IL64081A0 (en) Novel guanidine derivatives
IT1122111B (it) Procedimento per la purificazione di resorcina grezza
IT1188938B (it) Procedimento per la puricazione di acido ursodesossicolico
IT8049291A0 (it) Procedimento per la depurazione di pentaeritritolo
IT8067154A0 (it) Metodo per la produzione di sisomicina
RO82920A (ro) Compozitie pentru tratarea fibrelor de sticla
PT88551A (pt) Process for the preparation of curable compositions suitable for use as sealants
IT7922250A0 (it) Metodo per la purificazione di caprolattame grezzo.
ATE51000T1 (de) Verfahren zur herstellung von alphaaminoalkylphosphon- und von alphaaminoalkylphosphins|uren.
DD137807A3 (de) Anlage zur kultivierung von mikroorganismen
KR860004852A (ko) 알릴아민 및 이의 제조방법
IT1141264B (it) Processo per la purificazione di glicosaminoglicani
IT1171279B (it) Procedimento per la purificazione di 2-mercaptobenzotiazolo
BR8604750A (pt) Derivado de fenoxietanona,processo para a preparacao de compostos,composicao e processo para combater ou proteger uma infestacao por microorganismos
DK277787A (da) Azaphospholener og deres anvendelse
BR8800810A (pt) Composicao de hidrofobacao para couro
IT8448663A0 (it) Composizione di rivestimento trasparente antiappannante
IT7924653A0 (it) Procedimento di purificazione di caprolattame grezzo.
IT1165286B (it) Procedimento per la raffinazione di oli minerali

Legal Events

Date Code Title Description
MKLA Lapsed
MKLA Lapsed

Effective date: 19950417